$8.00
+0.15(1.90%)
Mkt Cap $227M
$5.90
$23.16
52-Week Range
At A Glance
1
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States.
2
Revenue is primarily driven by Collaboration Revenue (90.6%) and Grant (9.4%).
3
Most recently: of this Current Report on Form 8-K, including the Press Release, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 19 (2026-03-03).
$227M
Market Cap
$77M
Revenue
-$68M
Net Income
Employees174
Fundamentals
How The Business Makes Money
Revenue by Segment
Collaboration Revenue90.6%($725M)
Grant9.4%($76M)
Revenue by Geography
Foreign Countries100%($360M)
Activity
Analyst View
Company Profile
CIK0001768224
ISINUS03969T1097
CUSIP03969T109
Phone858 900 2660
Address10628 Science Center Drive, San Diego, CA, 92121, US
SEC EDGAR